These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 13351284)

  • 1. [Hypoglycemic effect of new sulfonamide N1-sulfanilyl-N2-n-butyl-carbamide (Bz 55) in surgical patients].
    CORTINOVIS R
    Riforma Med; 1956 Jul; 70(27):764-7. PubMed ID: 13351284
    [No Abstract]   [Full Text] [Related]  

  • 2. [Oral treatment of diabetes mellitus with a sulfonamide derivative; N1-sulfanilyn-N2-n-butyl carbamide].
    ANGELI G; TEDESCHI G
    Minerva Med; 1956 Jun; 47(50):1968-75. PubMed ID: 13348337
    [No Abstract]   [Full Text] [Related]  

  • 3. [Experimental research on absorption and hypoglycemic action of N1-sulfanilyl-N2-n-butyl urea and N-4-methyl-benzene sulfonyl-N1-butyl urea, rectal administration].
    GIANNI AM
    Boll Soc Ital Biol Sper; 1956; 32(10-11):1289-91. PubMed ID: 13426314
    [No Abstract]   [Full Text] [Related]  

  • 4. [Severe hypoglycemic reactions during peroral treatment of diabetes with N1-sulfanilyl-n-2-n-butylcarbamid (BZ 55)].
    BENDFELDT E; OTTO H
    Munch Med Wochenschr; 1956 Aug; 98(35):1136-7. PubMed ID: 13369451
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effect of N1-sulfanilyl-N2-n-butyl carbamide on the progress of alloxan diabetes in rabbits and on the glucagon content in dogs pancreas].
    CZYZK A
    Arzneimittelforschung; 1956 Dec; 6(12):700-1. PubMed ID: 13395925
    [No Abstract]   [Full Text] [Related]  

  • 6. [Hypoglycemic effect of various sulfamides administered orally; treatment of diabetes mellitus with BZ 55].
    SCALABRINO R; PASQUARIELLO G
    Minerva Med; 1956 Jan; 47(9):270-3. PubMed ID: 13309001
    [No Abstract]   [Full Text] [Related]  

  • 7. [Treatment of ten cases of diabetes with oral hypoglycemic sulfonamide BZ 55 or nadisan].
    FERNANDEZ BASABE E; GALAN J; OLIVER A; OLIVER-PASCUAL E; PURAS E
    Rev Esp Enferm Apar Dig Nutr; 1956; 15(2):478-88. PubMed ID: 13370980
    [No Abstract]   [Full Text] [Related]  

  • 8. [Antidiabetic effect of a new sulfonamide].
    TOLOMELLI E; PELLEGRINI R; POPPI A
    Riforma Med; 1956 Feb; 70(7):180-3. PubMed ID: 13311263
    [No Abstract]   [Full Text] [Related]  

  • 9. [Ambulatory treatment of diabetics with a hypoglycemic sulfonamide].
    RAMEL C; HOFSTETTER JR
    Praxis; 1956 Apr; 45(16):365-9. PubMed ID: 13335688
    [No Abstract]   [Full Text] [Related]  

  • 10. [Preliminary experience with the oral antidiabetic remedy BZ 55].
    SVANBORG A; SOLVELL L
    Sven Lakartidn; 1956 May; 53(20):1311-20. PubMed ID: 13337651
    [No Abstract]   [Full Text] [Related]  

  • 11. [BZ-55, a peroral antidiabetic remedy with a possible glucagon-restraining effect].
    ANDERSSON B
    Sven Lakartidn; 1956 Jan; 53(2):57-64. PubMed ID: 13311777
    [No Abstract]   [Full Text] [Related]  

  • 12. [The Langerhans islands of diabetics after treatment with the oral antidiabetic, BZ 55].
    FERNER H; RUNGE W
    Dtsch Med Wochenschr; 1956 Mar; 81(10):331-3. PubMed ID: 13317606
    [No Abstract]   [Full Text] [Related]  

  • 13. [Studies on the total & renal clearance of N1-sulfanilyl-N2-n-butyl-carbamide (nadisan)].
    KLAUS D; STRIPECKE W
    Z Gesamte Inn Med; 1957 Apr; 12(7):289-94. PubMed ID: 13456727
    [No Abstract]   [Full Text] [Related]  

  • 14. The relation of various variables to the hypoglycemic action of 1-butyl-3-p-tolylsulfonylurea in patients with diabetes mellitus.
    DIENGOTT D; DOLGER H; MIRSKY IA
    Metabolism; 1956 Nov; 5(6 Part 2):875-93. PubMed ID: 13378057
    [No Abstract]   [Full Text] [Related]  

  • 15. BZ-55 (CARBUTAMIDE): experimental and clinical studies of an oral antidiabetic agent.
    Can Med Assoc J; 1956 Jun; 74(12):957-98. PubMed ID: 13329939
    [No Abstract]   [Full Text] [Related]  

  • 16. [Examination of steroids in therapy with N'-sulfanilyl-N2-N-butylcarbamid (nadisan)].
    RAUSCH-STROOMANN JG; SAUER H
    Klin Wochenschr; 1956 Jul; 34(25-26):707-8. PubMed ID: 13347046
    [No Abstract]   [Full Text] [Related]  

  • 17. [A brief contribution on cutaneous side effects of the oral antidiabetic remedy BZ 55 (nadisan)].
    WALTHER H; WALZ H
    Ther Ggw; 1956 May; 95(5):183-4. PubMed ID: 13352317
    [No Abstract]   [Full Text] [Related]  

  • 18. [A new antidiabetic N-sulfanilyl-N'-butyl urea (BZ 55); preliminary results].
    CHAIA J
    Rev Med Moyen Orient; 1957; 14(1):47-50. PubMed ID: 13454198
    [No Abstract]   [Full Text] [Related]  

  • 19. [Treatment of aged diabetics with hypoglycemic sulfonamides].
    DEMOL O; MAHAUX J
    Acta Clin Belg; 1956; 11(3):275-98. PubMed ID: 13339058
    [No Abstract]   [Full Text] [Related]  

  • 20. Hypoglycemic effects of 1-butyl-3-p-toluene sulfonylurea given orally in human diabetic subjects; a preliminary report.
    MILLER M; CRAIG JW
    Metabolism; 1956 Mar; 5(2):162-4. PubMed ID: 13296878
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.